Daxor
7 hedge funds and large institutions have $715K invested in Daxor in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.14% less ownership
Funds ownership: 3.52% → 3.38% (-0.14%)
18% less capital invested
Capital invested by funds: $867K → $715K (-$152K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$14.9K |
| 2 |
Renaissance Technologies
New York
|
+$8.13K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$470 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$50K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$2K |
DXR Hedge Fund Activity: Q3 2017 in Review
7 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q3 2017, worth a combined $715K — down 18% from $867K a quarter earlier.
Fund positioning in DXR was balanced in Q3 2017: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $14.9K. The largest seller was Vanguard Group, cutting an estimated $50K.
- 7 institutional investors held Daxor (DXR) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $715K of Daxor stock for Q3 2017, down 18% quarter-over-quarter.
- 2 funds opened new Daxor positions in Q3 2017 and 2 closed out, a net change of 0 holders.
- The largest Daxor buyer in Q3 2017 was UBS Group, an estimated $14.9K added.
- The largest Daxor seller in Q3 2017 was Vanguard Group, an estimated $50K sold.
Based on aggregated 13F filings for Q3 2017.